FDA Greenlights Arcellx’s Revitalized Clinical Trial After Partial Hold

WASHINGTON D.C. – The FDA has cleared Arcellx to resume its iMMagine-1 Phase II clinical program for its CART-ddBCMA treatment following a partial clinical hold. This treatment is for patients with relapsed or refractory multiple myeloma. The trial, which is being carried out in collaboration with Gilead’s Kite Pharma, had been put on hold in … Read more

Here are some possible new headlines for this article: 1. “Activity on the Rise: Solar Max 2024 Tightens its Grip with Four M Flares” 2. “Fire on Earth’s Sun: Active Regions Spouting Four M Flares in 24 Hours” 3. “Hold on Tight: Earth’s Sun Sets 2024’s Skies Ablaze with Four M Flares” 4. “Countdown to Solar Max: Earth’s Sun Fires Off Four M Flares in a Day” 5. “Solar Max 2024: Earth’s Sun Delivers Stunning Performance with Four M Flares” Remember, the headline should be engaging and eye-catching to draw the attention of potential readers. It should also be relevant and accurately represent the content of the article.

From College Park, Maryland, the EarthSky Sun News team brings you the latest update on solar activity. As of January 12, 2024, the sun has been particularly active, with four M flares recorded on its path to Solar Max, the peak of the sun’s 11-year cycle expected in 2024. Over the past 24 hours, the … Read more

Mourners march and hold mass hug to remember Prague shooting victims

PRAGUE, Czech Republic – Hundreds of mourners gathered in Prague to honor the victims of a shooting at a hospital in Ostrava. The mourners marched through the city and held a mass hug to express their condolences and show unity in the face of tragedy. The shooting, which occurred on January 4th, resulted in the … Read more